Personalized Medicine

Foley’s Personalized Medicine attorneys counsel you on matters involving the development and IP protection of genetic testing procedures and mobile health care, payer coverage issues, and patient privacy protection, among many others.

Our clients operating in the personalized medicine space recognize the rewards in bringing new products to market, while acknowledging some of the uncertainties and risks involved as regulatory and policy issues remain unanswered. Foley’s Personalized Medicine attorneys offer experience in cross-disciplinary areas, including business and private equity, regulatory, privacy, reimbursement, health care, and IP to help you as you do business in this emerging space.

Foley's Personalized Medicine Bulletin provides insight on the latest developments on various related topics.

Representative Matters

Showing of
Planned and conducted an internal investigation in the United Arab Emirates related to alleged violations of the FCPA by executives of a Dubai/UAE subsidiary of a multinational pharmaceutical company.

Related Services


Federal Circuit Invalidates Patented Cancer Therapy
20 May 2019
Personalized Medicine Bulletin
PMC Releases "A Consumers Guide to Genetic Health Testing"
06 May 2019
Personalized Medicine Bulletin
Is 101 Relief in Sight?
17 April 2019
Personalized Medicine Bulletin
New Guidance from Federal Circuit for Computer-Implemented Medical Methods
11 March 2019
Personalized Medicine Bulletin
Konski Quoted on Myriad Patent Case
10 October 2014
Bloomberg BNA’s Patent, Trademark & Copyright Journal
Konski Quoted on Patent Office's Post-Myriad Guide
13 March 2014
FDA Week
Brinckerhoff Quoted on Mayo v. Prometheus
20 March 2012
Foley Attorneys File Amicus Brief Related to ACLU v. Myriad
11 January 2010